blog

    Pharmaceutical excipients are the non-API ingredients that help turn an active pharmaceutical ingredient (API) into a usable medicine. They give tablets bulk and strength, support consistent capsule filling, keep particles suspended in liquid medicines, and control the texture of creams and gels. Beyond shaping a dosage form, excipients can influence powder flow, tablet compression, stability, disintegration, dissolution, and drug release.   Common examples include lactose and microcrystalline cellulose (MCC) as fillers, povidone (PVP) as a binder, sodium starch glycolate and croscarmellose sodium as disintegrants, magnesium stearate as a lubricant, colloidal silicon dioxide as a glidant, and hydroxypropyl methylcellulose (HPMC) in binding or coating applications. These ingredients range from sugars and starches to cellulose derivatives, polymers, water, and oils. Although often called “inactive ingredients,” excipients are not necessarily functionally inert. Their purity, grade, concentration, and compatibility with the API all matter when selecting materials for safe, reliable drug manufacturing.   What Are Pharmaceutical Excipients?   Unlike active pharmaceutical ingredients (APIs), which provide a medicine's intended pharmacological action, pharmaceutical excipients support how the drug is formulated, manufactured, stored, and delivered. Their main functions include:   Manufacturing and processing: Excipients help powders flow, blend, compress, and fill consistently. Microcrystalline cellulose (MCC) supports tablet compression, colloidal silicon dioxide can improve powder flow, and magnesium stearate reduces friction during tablet ejection. These properties influence the performance of tablet presses and capsule filling machines. Dosage form structure and uniformity: Fillers such as lactose add bulk to low-dose formulations, while binders like povidone (PVP) help particles form strong tablets. Suitable excipients also support consistent tablet weight, capsule filling, and dose uniformity. Stability and protection: Antioxidants and buffers may help manage oxidation or pH-related stability. Preservatives help control microbial growth in formulations that require them. Film-forming polymers such as HPMC and ethylcellulose may provide protective coatings against environmental exposure. Disintegration and drug release: Sodium starch glycolate, croscarmellose sodium, and crospovidone help immediate-release tablets break apart after administration. Other polymers and coating materials can modify drug-release behavior, depending on the formulation. Patient acceptability and product consistency: Sweeteners and flavors improve the taste of oral medicines, while suspending agents, emulsifiers, and thickeners help maintain the texture and physical stability of syrups, suspensions, creams, and gels.   The key point: Excipients do more than hold a formulation together. Their type, grade, concentration, and...

  A desiccant in a pill bottle is a small packet or plastic canister placed alongside tablets or capsules to control moisture. The packet often contains silica gel, while other types use molecular sieves or clay. These materials trap water vapor inside the bottle, helping protect medicines from humidity. Without enough moisture protection, certain tablets can soften, stick together, or deteriorate during storage. Some capsule shells can also become too soft or brittle when humidity is unsuitable.   For example, effervescent tablets react readily with water, making moisture control especially important. A desiccant helps protect these tablets, but it works together with the bottle, cap, and seal rather than replacing them. Not every medicine needs a desiccant. Pharmaceutical manufacturers select the appropriate type and amount based on the drug's moisture sensitivity and packaging requirements.   What Is a Desiccant in a Pill Bottle and Why Is It Used?   A desiccant is a moisture-absorbing material placed inside a pill bottle to help keep tablets and capsules dry. It usually comes in a small sealed packet or plastic canister. The packet holds materials such as silica gel, which has millions of tiny pores that attract and hold water molecules. This process is called adsorption. Water vapor can enter the packet, but the desiccant particles remain enclosed.   Desiccant in pill bottle packaging addresses two main sources of moisture:   Moisture Already Inside the Bottle: When tablets or capsules are packaged, a small amount of humid air remains inside the container. Some medicines also contain moisture that can move between the product and the surrounding air. A desiccant helps reduce this humidity and maintain suitable storage conditions. Moisture Entering During Storage: Even a closed plastic bottle can allow small amounts of water vapor to pass through its walls or closure over time. A desiccant captures part of this incoming moisture, providing additional protection for moisture-sensitive medicines. Not every pill bottle needs a desiccant. Its use depends on the medicine's moisture sensitivity and the protection provided by the bottle, cap, and seal.   What Types of Desiccants Are Used in Pharmaceutical Packaging?   Pill bottle desiccants are classified by material and packaging form. Silica gel, molecular sieves, and clay capture water vapor; sachets, canisters, and caps hold those materials in different ways.   Common desiccant materials   Silica Gel: Porous beads or granules that attract water vapor. Silica gel desiccants are widely used for humidity control, and their moisture uptake generally increases as surrounding humidity rises. Pharmaceutical use requires a suitable finished packet, not simply industrial silica gel. Molecular Sieve: A porous zeolite that attracts water strongly, even when the surrounding air is already quite dry. Molecular...

    Blister packaging machine design supports GMP by reducing contamination risks, improving packaging material control, and making cleaning and changeover easier. Product-contact surfaces must be suitable for pharmaceutical use, feeding areas need to be accessible for residue removal, and material detection helps prevent continued operation with broken PVC film or aluminum foil. Pull-out forming, sealing, and punching tooling is designed to speed up tooling replacement when blister formats change.   Safety alarms, protective guards, and emergency stops address hazards around heated and moving machine parts. These features complement GMP requirements for equipment suitability, cleaning, and maintenance under FDA 21 CFR 211.63–211.67. Their effectiveness depends on appropriate equipment configuration, operating procedures, and functional checks. For pharmaceutical manufacturers, these design details influence product quality control, operator safety, and the time required for routine maintenance and batch changeovers.   What Does GMP Require from Blister Packaging Machine Design?   GMP does not prescribe one universal blister machine layout or require every model to have the same sensors. It requires manufacturers to use equipment suitable for its intended operation, maintain it in a controlled condition, and prevent contamination and packaging mistakes. Machine design makes those tasks easier—or harder—to carry out consistently.   A feeder with difficult-to-reach corners can retain tablet dust after a batch. Poor sealing-station access complicates inspection after a foil jam; disorganized material changeovers increase mix-up risks.   In the United States, FDA 21 CFR 211.63 covers appropriate equipment design and location; 211.65 addresses surfaces that contact drug products or in-process materials; and 211.67 covers written cleaning and maintenance procedures and their records. Section 211.130 also requires controls against packaging and labeling mix-ups, including checks before packaging begins. EU GMP Chapter 3 also calls for equipment layout and design that minimize errors and allow effective cleaning and maintenance.   A stainless steel frame or protective enclosure does not make a machine independently “GMP-certified.” Manufacturers must demonstrate that equipment, cleaning methods, operating procedures, and packaging controls work for their products. Mechanical safety requires a separate assessment.   Assess equipment by linking production risks to design features and test evidence.   How Does Machine Design Support Cleaning and Contamination Control?   Small contact points near feeders, guides, joints, and removable parts can retain powder or fragments. Hygienic design combines suitable materials with access for cleaning, inspection, and maintenance.   Product-Contact Materials and Accessible Surfaces   On a tablet or capsule blister line, the fe...

    CE marking for machinery means the manufacturer declares that a machine meets the EU requirements applicable to it. It is not an EU-issued approval, and third-party certification is not always required. For a capsule filling machine, tablet press, or blister packaging machine, conformity involves identifying hazards, applying appropriate safeguards, assessing relevant electrical and other requirements, and maintaining technical documentation.   For buyers, the key is to check the machine's Declaration of Conformity, instructions, and identification—not simply accept a PDF labeled “CE Certificate.” The documents should match the manufacturer, model, and delivered configuration. From 20 January 2027, Regulation (EU) 2023/1230 becomes the main EU machinery law. Understanding these requirements helps buyers verify a machine's safety documentation before purchase, shipment, or installation.   What Does CE Marking Mean for Machinery?   CE marking means the manufacturer takes responsibility for meeting the EU product requirements that apply to the machine. It is a legal conformity mark, not a quality ranking or a certificate awarded by an EU office.   Imagine two capsule fillers carrying the same CE logo. One has an interlocked access door; the other has a different guarding arrangement. The logo alone cannot explain whether either design controls its hazards adequately. You need the risk assessment behind the design, the relevant safeguards, and the required documents.   The marking also does not mean a machine is suitable for every pharmaceutical process. A machine can satisfy applicable machinery requirements while still needing site-specific qualification, cleaning validation, and integration work.   Is CE Marking the Same as a CE Certificate?   Not exactly. People often say “CE certified,” but CE marking and third-party certification are different things.   For many machinery types, the manufacturer can complete the permitted conformity assessment procedure without a Notified Body. For certain categories and assessment routes, an authorised third party must participate.   A PDF titled “CE Certificate” could be a voluntary test certificate, a laboratory report, or an actual Notified Body document. Its title does not tell you which. Ask for the signed EC Declaration of Conformity under the current Machinery Directive, or the EU Declaration of Conformity under the new Regulation, as appropriate.   Then check whether any additional certificate covers the exact model and the legislation claimed. An impressive-looking document for a different machine is not useful evidence.   Who Is Responsible for Compliance?   The manufacturer must identify applicable legislation, assess risks, apply protective measures, prepare technical documentation, complete the relevant conformity assessment, and provide the required declaration and instructions. Imp...

  A carton may say 10 mg while the blister inside contains 20 mg tablets, or a bottle may carry the previous batch's expiry date. Pharmaceutical labeling requirements address both the information patients need and the controls that connect it to the correct medicine.   US and EU labeling rules differ, but packaging teams face the same challenge: matching approved artwork, components, and variable data. The following explains the FDA and EU rules and how GMP controls and machines apply them.   What Information Must Appear on Pharmaceutical Labels?   Start with the finished pack in your hand. It may include an immediate container—the bottle or blister touching the medicine—an outer carton, and a leaflet. Their required information depends on the approved product and market; there is no global template.   Most pharmaceutical labels help a user answer three questions: What medicine is this? How should it be used safely? Can this pack be traced? The table explains common fields, not a universal list of legal requirements.   Information What it tells the reader or manufacturer Where it may appear Product name and strength Distinguishes one medicine or dose from another Bottle, blister, carton Active substance, dosage form and contents Identifies the formulation and pack presentation Usually prominent on outer packaging; as applicable elsewhere Directions, precautions and storage Helps people use and store the medicine correctly Package labeling and/or leaflet, according to the product Batch or lot number Connects packs to manufacturing and quality records Appropriate packaging levels Expiry date Identifies the approved dating limit Appropriate packaging levels Company or authorization details Identifies the responsible entity As required by the market Barcode or unique identifier Enables identification or traceability where required Location and format depend on the rule     A batch number and a serial number are not the same. All cartons from one production batch can share its lot number, while each carton may receive a different serial number under an applicable serialization system. A readable barcode can still be printed on the wrong product.   For code definitions, see our medicine label codes guide. Here we focus on regulatory requirements and packaging control.   What Are the FDA Pharmaceutical Labeling Requirements?   For medicines sold in the United States, the first distinction is prescription versus over-the-counter (OTC). They use different labeling formats. 21 CFR Part 201 governs drug labeling; Part 211 addresses controls against packaging mix-ups. Always start with the product's approved or otherwise applicable labeling.   Prescription drugs: the carton is not the full prescribing information   Prescription medicines need information on uses, dosing, contraindications, warnings, and adverse reactions. For products within their scope, 21 CFR 201.56 and 201.57 set...

  Pre-compression and main compression are two separate stages in a rotary tablet press. Pre-compression initially compacts the powder, helps particles settle and allows trapped air to escape when conditions are suitable. Main compression applies further pressure to form a tablet with the required strength. The key difference is that pre-compression prepares the powder bed, while main compression works on that already-compacted material.   Both stages affect tablet hardness, capping, lamination and production consistency. Their results also depend on the formulation, turret speed, punch design and how quickly pressure is applied and released. A higher force does not automatically produce a better tablet.   Core effects on tablet quality   Tablet strength: Changing pre-compression can change final hardness, even when the main compression setting stays the same. Speed and dwell time: Faster turret rotation gives the powder less time at each station, but the actual effect depends on the material and machine design. Capping and lamination: Pre-compression can help reduce defects linked to trapped air; other causes need different solutions. Machine design: Punch heads, compression rollers and tooling determine how the force reaches the powder. Consistent production: The right settings are those that produce acceptable tablets at the required speed, not those that follow a fixed force ratio.   1. What Is the Difference Between Pre-Compression and Main Compression in a Tablet Press?   Pre-compression begins powder densification; main compression completes the compaction needed for tablet strength and shape. Both stages use upper and lower punches working against compression rollers, but they act at different points in the production cycle.   How Does Each Compression Stage Work?   After filling, the die moves to the pre-compression station. The rollers bring the punches closer together, reducing the space occupied by powder or granules. Particles move into closer contact, larger air spaces become smaller and some air may escape. Depending on the material, particles can also begin to deform or break into smaller pieces. The rotary tablet press working principle explains the complete filling, compression and ejection sequence.   The pressure normally drops as the punches leave the first rollers. The partly formed tablet then reaches the main compression station, where further loading creates stronger contact between particles. Finally, the pressure is released and the tablet is pushed out of the die. Poorly matched or worn punches and dies can make these stages less consistent.   Comparison Pre-compression Main compression Position First compression station Second compression station Main purpose Settle and partly compact the powder Build final density and tablet strength What happens to particles Rearrangement, initial deformation and possible air release Further deformation and stronger particle bonding ...

  A recent New York Times article, “Americans Are Taking More Supplements Than Ever, Despite Experts’ Doubts,” pointed out that nearly 8 in 10 adults in the United States currently take at least one dietary supplement, while the global supplement industry is estimated to be worth around $228 billion.   As the supplement market continues to expand, manufacturers are no longer dealing with only standard tablets and capsules. Powders, granules, gummies and other supplement formats are becoming increasingly common, while packaging options now range from bottles and blister packs to stick packs, sachets and cartons.   For pharmaceutical and nutraceutical manufacturers, this makes machinery selection increasingly important. Choosing the right equipment is not only about matching the machine to the product, packaging format and required output. Manufacturers also need to consider whether the equipment can meet the regulatory expectations of the target market, whether sufficient technical and validation documentation can be provided, and whether reliable installation and after-sales support is available.   These factors become particularly important when sourcing pharmaceutical and supplement machinery internationally, including from China. A machine may be able to produce the required package, but that does not automatically mean it is suitable for installation, qualification and long-term operation in the manufacturer's target market.   In this article, we will look at the most common supplement packaging formats, the machinery typically used for each, and the key factors manufacturers should evaluate before selecting a production or packaging machine.   Common Supplement Packaging Formats and Recommended Machinery   Different supplement products require different packaging processes. Before selecting a machine, manufacturers should first confirm the product form, the final packaging format and the expected production capacity.   The table below provides a quick overview of common supplement products, their typical packaging formats and the main factors to consider when selecting the corresponding equipment.   Supplement Product Common Packaging Format Recommended Packaging Machine Key Selection Focus Capsules and tablets Bottles Counting and bottling line Counting accuracy, bottle size, output, changeover Capsules and tablets Blister packs Blister packaging machine Packaging material, blister layout, sealing quality, tooling changeover, cleaning Powders and granules Stick packs / sachets Stick pack / sachet packaging machine Filling accuracy, product flowability, pack size, number of lanes Gummies Bottles / jars Counting and bottling machine Product size, stickiness, feeding stability, counting accuracy Finished bottles, blisters and stick packs Cartons Cartoning machine Product dimensions, carton size, feeding method, leaflet insertion   These specifications help determine the basic ...

    A dosage form is the physical form in which a drug product is produced and supplied, such as a tablet, capsule, solution, cream, injection, inhalation product, or patch. It combines an active pharmaceutical ingredient (API) with excipients and a product design that makes the medicine suitable for a particular route of administration. FDA terminology lists dosage forms separately from routes of administration, while USP <1151> provides general descriptions and manufacturing principles for commonly used pharmaceutical dosage forms.   For pharmaceutical manufacturers, dosage form is more than a label on the finished product. It affects formulation, material handling, unit-dose formation, release behavior, primary packaging, storage, and the equipment needed to produce the product consistently. This guide explains the main types of dosage forms, gives practical examples, separates dosage form from route, dose, and strength, and connects those concepts to pharmaceutical production.   1. What Is a Pharmaceutical Dosage Form?   A pharmaceutical dosage form is the completed form of a drug preparation in which a dose of medication is presented for use. NLM MeSH describes dosage forms as completed pharmaceutical preparations containing prescribed doses, while FDA lists forms such as tablets, capsules, creams, solutions, suspensions, injections, patches, and suppositories.   The dosage form is not the same thing as the API. The active pharmaceutical ingredient (API) is the active drug substance. Excipients are inactive formulation components used for functions such as filling, binding, disintegration, lubrication, coating, viscosity control, preservation, or product stability. The dosage form is the finished configuration created from those materials.   For example, consider a product labeled as a 500 mg tablet for oral use. Tablet is the dosage form, oral is the route of administration, 500 mg is the strength per tablet, and the dose is the amount actually administered at one time. Keeping these terms separate is important because regulators and pharmacopeial standards treat dosage form, route, strength, and dosing information as distinct product attributes.   2. What Are the Main Types of Dosage Forms?     There is no single classification that covers every dosage form without overlap. Dosage forms can be organized by physical characteristics, route of administration, release behavior, or delivery system. USP <1151> uses physical-form descriptions, while FDA and EDQM maintain terminology that separately identifies dosage forms and routes of administration.   The following table summarizes common dosage-form families. Some rows describe physical forms, while others describe clinically familiar delivery families, so the categories should not be treated as mutually exclusive.   Category Common Examples Typical Routes Practical Characteristics Solid dosage forms Tablets, capsules, pow...

  Liquid-filled hard capsules use a two-piece hard shell to hold compatible liquids, suspensions, or semisolids. After dosing, the cap and body are locked and, where the formulation requires it, sealed at the cap-body joint. Unlike powder filling, liquid capsule production puts tighter control on formulation flow, shell compatibility, dose repeatability, and seal integrity.   In liquid-filled hard capsule production, the formulation, dosing system, capsule shell, sealing method, and post-sealing conditions have to work together. This guide follows that process from formulation selection and filling through locking, sealing, drying or curing, inspection, and equipment choice.   What Are Liquid-Filled Hard Capsules?   Liquid-filled hard capsules (LFHCs) are preformed two-piece capsules with a longer body for the fill and a shorter cap that closes over it. They can use hard gelatin or polymer shells such as HPMC, but the formulation and process must be compatible with the selected shell.   Structure of a Liquid-Filled Hard Capsule   A liquid-filled hard capsule has four working parts:   Capsule body: holds the metered formulation. Capsule cap: closes over the filled body. Liquid or semi-solid fill: the dosed formulation. Cap-body joint: the overlapping interface that provides mechanical closure and, when needed, receives the seal. Locking joins the cap and body; sealing closes off the joint. For liquid fills, that extra seal can reduce leakage through the cap-body interface and limit unwanted ingress during handling and storage.     Gelatin vs HPMC Capsule Shells   Gelatin and HPMC do not behave the same around every liquid formulation. Moisture, solvents, excipients, and storage conditions can change shell brittleness, deformation, mass, or integrity, so shell choice has to be tested with the actual formulation.   In practice, neither gelatin nor HPMC is automatically the better option. Their moisture behavior and mechanical response differ, while full formulation-shell compatibility is evaluated in the next section.     Liquid-Filled Hard Capsules vs Softgels   Both LFHCs and softgels can carry liquids or semisolids, but they are made differently. A softgel forms a flexible shell around the fill during encapsulation; an LFHC starts with a preformed two-piece hard shell.   That difference changes the filling equipment, dosing method, shell behavior, and sealing step. LFHCs are useful when a product needs a hard-capsule format with a compatible liquid or semisolid fill.   What Can Be Filled Into Hard Capsules?   Hard capsules can hold oils, non-aqueous solutions, suspensions, and selected semisolids or pastes, but the formulation still has to be compatible with the shell, dosing system, and sealing process.     Oils and Lipid-Based Formulations   Oils and lipid-based fills are common LFHC applications because positive-displacement dosing can meter the...